Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Clinical trial NCT06216093 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06216093
Sponsor: EuBiologics Co.,Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections Respiratory Syncytial Virus (RSV)

Start date: 2024-05-08
Primary completion: 2025-07-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.